sodium ferulate

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: sodium ferulate
• 英文别名: sodium;4-[(E)-2-carboxyethenyl]-2-methoxyphenolate
• 化学式: C₁₀H₉O₄*Na
• 分子量: 216.169
• InChiKey: NCTHNHPAQAVBEB-WGCWOXMQSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -2.83
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  69.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  阿魏酸 在 sodium hydroxide 作用下， 以 水 为溶剂， 生成 sodium ferulate
  参考文献：
  名称：

  288.15至318.15 K温度下水中选定肉桂酸钠盐的摩尔电导率和缔合常数

  摘要：

  肉桂酸，4-羟基肉桂酸（对香豆酸），3,4-二羟基肉桂酸（咖啡酸），4-羟基-5-甲氧基肉桂酸（阿魏酸）和3,5-二甲氧基钠盐的水溶液的电导率在288.15至318.15 K的温度范围（T）内以5 K的间隔测量了-4-羟基肉桂酸（芥子碱）酸。极限摩尔电导率Λ米Ø使用低浓度化学模型（lcCM）获得离子缔合常数（K A o）。确定了所研究阴离子的极限离子电导率和Eyring活化电荷转移焓。

  DOI：

  10.1016/j.molliq.2019.111370

文献信息

• Design, Synthesis, and<i>In Vitro</i>Antiplatelet Aggregation Activities of Ferulic Acid Derivatives
  作者：Peng-Xuan Zhang、Hang Lin、Cheng Qu、Yu-Ping Tang、Nian-Guang Li、Jun Kai、Guanxiong Shang、Baoquan Li、Li Zhang、Hui Yan、Pei Liu、Jin-Ao Duan

  DOI：10.1155/2015/376527

  日期：——

  In order to discover new compounds with antiplatelet aggregation activities, some ferulic acid (FA) derivatives were designed and synthesized. The in vitro antiplatelet aggregation activities of these compounds were assessed by turbidimetric test. The results showed that the target compound 7f had potent antiplatelet aggregation activity with its IC50 27.6 μmol/L, and 7f can be regarded as a novel potent

  为了发现具有抗血小板聚集活性的新化合物，设计并合成了一些阿魏酸（FA）衍生物。这些化合物的体外抗血小板聚集活性通过比浊试验进行评估。结果表明，目标化合物7f具有较强的抗血小板聚集活性，其IC50为27.6 μmol/L，7f可作为一种新型的有效抗血小板聚集候选物。
• BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF
  申请人：SENOMYX, INC.

  公开号：US20160376263A1

  公开（公告）日：2016-12-29

  The present invention includes compounds and compositions known to modify the perception of bitter taste, and combinations of said compositions and compounds with additional compositions, compounds, and products. Exemplary compositions comprise one or more of the following: cooling agents; inactive drug ingredients; active pharmaceutical ingredients; food additives or foodstuffs; flavorants, or flavor enhancers; food or beverage products; bitter compounds; sweeteners; bitterants; sour flavorants; salty flavorants; umami flavorants; plant or animal products; compounds known to be used in pet care products; compounds known to be used in personal care products; compounds known to be used in home products; pharmaceutical preparations; topical preparations; cannabis-derived or cannabis-related products; compounds known to be used in oral care products; beverages; scents, perfumes, or odorants; compounds known to be used in consumer products; silicone compounds; abrasives; surfactants; warming agents; smoking articles; fats, oils, or emulsions; and/or probiotic bacteria or supplements.

  本发明涵盖已知用于改变苦味感知的化合物和组合物，以及所述组合物和化合物与额外的组合物、化合物和产品的组合。示例组合物包括以下一种或多种：冷却剂；无活性药物成分；活性药用成分；食品添加剂或食品；调味剂或调味增强剂；食品或饮料产品；苦味化合物；甜味剂；苦味剂；酸味调味剂；咸味调味剂；鲜味调味剂；植物或动物产品；已知用于宠物护理产品中的化合物；已知用于个人护理产品中的化合物；已知用于家用产品中的化合物；制药制剂；局部制剂；大麻衍生或与大麻相关的产品；已知用于口腔护理产品中的化合物；饮料；香味、香水或除臭剂；已知用于消费品中的化合物；硅化合物；磨料；表面活性剂；发热剂；吸烟物品；脂肪、油脂或乳化剂；和/或益生菌或补充剂。
• Pharmaceutical Product Comprising a P38 Kinase Inhibitor and a Second Active Ingredient
  申请人：Cooper Anne Elizabeth

  公开号：US20120028941A1

  公开（公告）日：2012-02-02

  The invention provides a pharmaceutical product, kit or composition comprising a first active ingredient which is N-Cyclopropyl-3-fluoro-4-methyl-5[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxo-1(2H)-pyrazinyl]-benzamide or a salt thereof, and a second active ingredient selected from: a non-steroidal Glucocorticoid Receptor (GR Receptor) Agonist; an antioxidant; a β2 adrenoceptor agonist; a CCR1 antagonist; a chemokine antagonist (not CCR1); a corticosteroid; a CRTh2 antagonist; a DPI antagonist; an Histone Deacetylase activator; an IKK2 kinase inhibitor; a COX inhibitor; a lipoxygenase inhibitor; a leukotriene receptor antagonist; a MABA compound; an MPO inhibitor; a muscarinic antagonist; a PDE4 inhibitor; a PPARγ agonist; a protease inhibitor; a Statin; a thromboxane antagonist; a vasodilator; or, an ENAC blocker (Epithelial Sodium-channel blocker); and its use in the treatment of respiratory disease.

  该发明提供了一种制药产品、套装或组合物，包括第一活性成分N-环丙基-3-氟-4-甲基-5-[3-[[1-[2-[2-(甲氨基)乙氧基]苯基]环丙基]氨基]-2-氧代-1(2H)-吡嗪基]-苯甲酰胺或其盐，以及从以下选取的第二活性成分：非类固醇糖皮质激素受体（GR受体）激动剂；抗氧化剂；β2肾上腺素受体激动剂；CCR1拮抗剂；趋化因子拮抗剂（非CCR1）；皮质类固醇；CRTh2拮抗剂；DPI拮抗剂；组蛋白去乙酰化酶激活剂；IKK2激酶抑制剂；COX抑制剂；脂氧合酶抑制剂；白三烯受体拮抗剂；MABA化合物；MPO抑制剂；毛细血管抗药性剂；PDE4抑制剂；PPARγ激动剂；蛋白酶抑制剂；他汀类药物；前列腺素拮抗剂；扩血管剂；或者ENAC拮抗剂（上皮钠通道拮抗剂）；以及其在呼吸系统疾病治疗中的用途。
• Branched Polymeric Emulsifiers
  申请人：Lubrizol Advanced Materials, Inc.

  公开号：US20150218312A1

  公开（公告）日：2015-08-06

  The present invention relates to esterified glycerylated alkyl glycoside and to a process for making same. The esterified glycerylated alkyl glycoside have one or more polyglyceryl moieties and one or more acyl moieties, wherein all of the one or more acyl moieties are situated on the one or more polyglyceryl moieties via an ester linkage. These compounds have been found to be useful as emulsifiers and coemulsifiers in the formulation of a phase stable emulsions suitable for use in personal care, home care, industrial and institutional, and health care applications.

  本发明涉及酯化的甘油化烷基葡糖苷以及制备该化合物的方法。所述的酯化的甘油化烷基葡糖苷具有一个或多个聚甘油基团和一个或多个酰基团，其中所有的一个或多个酰基团通过酯键位于一个或多个聚甘油基团上。已发现这些化合物在制备适用于个人护理、家庭护理、工业和机构、以及医疗保健应用的相稳定乳化剂和共乳化剂方面具有实用性。
• [EN] WATER-SOLUBLE MINERAL FERULATES AND THEIR METHOD OF PREPARATION<br/>[FR] FÉRULATES MINÉRAUX HYDROSOLUBLES ET LEUR PROCÉDÉ DE PRÉPARATION
  申请人：MAJEED MUHAMMED

  公开号：WO2020146635A1

  公开（公告）日：2020-07-16

  The present invention discloses novel water-soluble mineral ferulates and mineral dihydroferulates, for use as a mineral and ferulic acid supplement. More specifically, the invention discloses a composition comprising water soluble calcium ferulate dihydrate or magnesium ferulate or calcium/magnesium dihydro ferulate for use as a calcium/magnesium and ferulic acid / dihydroferulic acid supplement and the method of their preparation.

  本发明公开了新型水溶性矿物酯和矿物二羟基酯，用作矿物和香草酸补充剂。更具体地，本发明公开了一种包含水溶性钙香草酸二水合物或镁香草酸盐或钙/镁二羟基香草酸盐的组合物，用作钙/镁和香草酸/二羟基香草酸补充剂以及它们的制备方法。